10.1002/chem.202000232
Chemistry - A European Journal
FULL PAPER
15.5 min; τminor = 17.8 min. [α]D27.7 = -7.29 (c 1.43, acetone, 41% ee).
8.29-8.35 (m, 2Ha + 2 Hb, Ar-H), 10.14 (d, J = 5.6 Hz, 1Hb, (RC=O)NHR),
10.37 (d, J = 6.3 Hz, 1Ha, (RC=O)NHR). 13C-NMR (75 MHz, DMSO-d6) δ
12.7 (CH3), 13.3 (CH3), 14.0 (CH3), 22.1 (CH2), 25.2 (CH2), 25.7 (CH2),
27.3 (CH2), 28.6 (CH2), 28.6 (CH2), 29.4 (CH2), 31.1 (CH2), 31.1 (CH2),
61.6 (NCHRR’), 62.2 (NCHRR’), 83.9 (RCHR’NO2), 84.3 (RCHR’NO2),
123.5 (2 x CAr-H), 123.6 (2 x CAr-H), 128.7 (2 x CAr-H), 128.7 (2 x CAr-H),
138.6 (CAr), 138.7 (CAr), 149.1 (CAr(a) + CAr(b)), 163.9 (C=O), 164.4
(C=O). HRMS (ESI+) calcd for [NaC16H24N4O5]+ 375.1639; found
375.1645 [M + Na]+.
{lit.[6] [α]D25 = -10.5 (c 0.31, acetone) for (S)-4na, 26% ee}.
4-Nitro-N'-(3-nitrobutan-2-yl)benzohydrazide (4gb)
From hydrazone 1g (20.72 mg, 0.1 mmol) and nitroethane (2b) (1 mL
12.6 mmol), after seven days at -20 °C, compound 4gb was purified by
column chromatography in n-hexane/ethyl acetate 7:3 to afford 18.46 mg
of a mixture of diastereomers (1.4:1 d.r.) as a yellow solid (65% yield).
The corresponding ee (54%) was determined respect to the major
diastereomer by HPLC using
a Daicel Chiralpak IC column (n-
N'-(4-Methyl-2-nitrohexan-3-yl)-4-nitrobenzohydrazide (4lb)
hexane/tetrahydrofuran 90:10, flow rate 1 mL·min-1, λ = 241.7 nm):
τmajor = 27.0 min; τminor = 36.5 min. M.p. 111-113 °C. IR (cm-1) 3242
(N-H), 3092, 2988, 1640 (C=O), 1598, 1541 (N-H), 1522 (NO2), 1451,
1392, 1344 (NO2), 1321, 1307, 871, 849, 690. 1H-NMR (300 MHz,
DMSO-d6) δ 1.04 (d, J = 6.6 Hz, 3Ha, RCH3), 1.09 (d, J = 6.7 Hz, 3Hb,
RCH3), 1.46 (d, J = 6.7 Hz, 3Ha, RCH3), 1.51 (d, J = 6.7 Hz, 3Hb, RCH3),
3.51-3.66 (m, 1Ha + 1Hb, NCHRR’), 4.73-4.86 (m, 1Ha + 1Hb, RCHR’NO2),
5.39 (dd, J1 = 5.5 Hz, J2 = 4.5 Hz, 1Hb, N-NH-C), 5.49 (t, J = 6.0 Hz, 1Ha,
N-NH-C), 7.98-8.07 (m, 2Ha+2Hb, Ar-H), 8.29-8.34 (m, 2Ha+2Hb, Ar-H),
10.20 (d, J = 5.6 Hz, 1Hb, (RC=O)NHR), 10.33 (d, J = 6.3 Hz, 1Ha,
(RC=O)NHR). 13C-NMR (75 MHz, DMSO-d6) δ 13.5 (CH3), 13.9 (CH3),
14.1 (CH3), 14.8 (CH3), 57.3 (NCHRR’), 57.8 (NCHRR’), 85.0
(RCHR’NO2), 85.1 (RCHR’NO2), 123.6 (2 x CAr-H), 123.6 (2 x CAr-H),
128.7 (2 x CAr-H(a) + 2 x CAr-H(b)), 138.6 (CAr), 138.7 (CAr), 149.1 (CAr(a)
From hydrazone 1l (0.1 mmol, 24.93 mg, 0.1 mmol) and nitroethane (2b)
(1 mL, 12.6 mmol), after seven days at -20 °C, compound 4lb was
purified by column chromatography in n-hexane/ethyl acetate 8:2 to
afford 8.16 mg of a mixture of diastereomers (2.4:1 d.r.) as a pale yellow
solid (25% yield). The corresponding ee (77%) was determined by HPLC
using a Daicel Chiralpak IC column (n-hexane/tetrahydrofuran 90:10,
flow rate 1 mL·min-1, λ = 255.5 nm): τmajor = 27.8 min; τminor = 24.7 min.
M.p. 132-134 °C. IR (cm-1) 3263 (N-H), 2953, 2867, 1644 (C=O), 1599,
1548 (N-H), 1517 (NO2), 1468, 1387, 1343 (NO2), 1302, 870, 851, 718.
1H-NMR (300 MHz, DMSO-d6) δ 0.85-1.23 (m, 6Ha + 6Hb, RCH3), 1.31-
1.43 (m, 4H, RCH2R’), 1.46-1.51 (m, 3Ha + 3Hb, RCH3), 1.79-1-94 (m,
1Ha + 1Hb, R2CHR’), 3.48-3.56 (m, 1H, NCHRR’), 3.65-3.72 (m, 1H,
NCHRR’), 4.69-4.77 (m, 1H, RCHR’NO2), 4.81-4.89 (m, 1H, RCHR’NO2),
5.28-5.31 (m, 1H, N-NH-C), 5.40-5.44 (m, 1H, N-NH-C), 7.93-7.97 (m,
2H, Ar-H), 8.04-8.08 (m, 2H, Ar-H), 8.29-8.35 (m, 2Ha + 2Hb, Ar-H), 10.13
(d, J = 5.4 Hz, 1H, (RC=O)NHR), 10.37 (d, J = 6.3 Hz, 1H, (RC=O)NHR).
13C-NMR (300 MHz, DMSO-d6) δ 12.7 (CAlk), 12.7 (CAlk), 21.7 (CAlk), 22.1
(CAlk), 23.0 (CAlk), 23.6 (CAlk), 24.3 (CAlk), 24.4 (CAlk), 36.5 (CH2), 38.6
(CH2), 59.8 (NCHRR’), 60.5 (NCHRR’), 84.0 (RCHR’NO2), 84.5
(RCHR’NO2), 123.6 (2 x CAr-H), 123.7 (2 x CAr-H), 128.8 (2 x CAr-H),
128.8 (2 x CAr-H), 138.6 (CAr), 138.8 (CAr), 149.2 (CAr), 149.2 (CAr), 164.2
(C=O), 164.5 (C=O). Exact mass calculated for [NaC14H20N4O5]+ [M +
Na]+ 347.1326; found 347.1321.
+
CAr(b)), 164.1 (C=O), 164.6 (C=O). HRMS (ESI+) calcd for
[NaC11H14N4O5]+ 305.0856; found 305.0869 [M + Na]+.
4-Nitro-N'-(2-nitropentan-3-yl)benzohydrazide (4jb)
From hydrazone 1j (24.11 mg, 0.1 mmol) and nitroethane (2b) (1 mL,
12.6 mmol), after seven days at -20 °C, compound 4jb was purified by
column chromatography in n-hexane/ethyl acetate 7:3 to afford 11.72 mg
of a mixture of diastereomers (1.7:1 dr) as a yellow solid (40% yield). The
corresponding ee (50%) was determined by HPLC using a Daicel
Chiralpak IC column (n-hexane/tetrahydrofuran 90:10, flow rate
1
mL·min-1, λ = 256.7 nm): τmajor = 32.2 min; τminor = 25.5 min. M.p. 81-
4-Nitro-N'-(4-nitro-1-phenylpentan-3-yl)benzohydrazide (4nb)
83 °C. IR (cm-1) 3251 (N-H), 3082, 2968, 1627 (C=O), 1596, 1546 (N-H),
1
1519 (NO2), 1448, 1390, 1338 (NO2), 1318, 1302, 861, 847, 697. H-
From hydrazone 1n (29.73 mg, 0.1 mmol) and nitroethane (2b) (1 mL,
12.6 mmol), after seven days at -20 °C, compound 4nb was purified by
column chromatography in n-hexane/ethyl acetate 8:2 to afford 9.36 mg
of a mixture of diastereomers (1.7:1 d.r.) as a yellow oil a yield of 41%
(yellow oil). The corresponding ee (73%) was determined by HPLC using
a Daicel Chiralpak IC column (n-hexane/ethyl acetate 85:15, flow rate 1
mL·min-1, λ = 247.1 nm): τmajor = 14.1 min; τminor = 15.6 min. IR (cm-1)
3284 (N-H), 2923, 1656 (C=O), 1600, 1544 (N-H), 1522 (NO2), 1453,
1391, 1344 (NO2), 1298, 866, 849, 699. 1H-NMR (300 MHz, DMSO-d6) δ
1.49-1.52 (m, 3Ha + 3Hb, RCH3), 1.59-1.79 (m, 2Ha + 2Hb, RCH2R’), 2.66-
2.93 (m, 2Ha + 2Hb, RCH2R’), 3.42-3.50 (m, 1H, NCHRR’), 3.62-3.64 (m,
1H, NCHRR’), 4.79-4.93 (m, 1Ha + 1Hb, RCHR’NO2), 5.50-5.53 (m, 1H,
N-NH-C), 5.67 (t, J = 6.0 Hz, 1H, N-NH-C), 7.16-7.31 (m, 5Ha + 5Hb, Ar-
H), 7.94-7.99 (m, 2H, Ar-H), 8.04-8.08 (m, 2H, Ar-H), 8.30-8.35 (m, 2Ha +
2 Hb, Ar-H), 10.18 (d, J = 5.6 Hz, 1H, (RC=O)NHR), 10.41 (d, J = 6.3 Hz,
1H, (RC=O)NHR). 13C-NMR (75 MHz, DMSO-d6) δ 12.9 (CH3), 13.7
(CH3), 29.0 (CH2), 29.6 (CH2), 31.3 (CH2), 31.5 (CH2), 61.4 (NCHRR’),
62.0 (NCHRR’), 83.9 (RCHR’NO2), 84.2 (RCHR’NO2), 123.5 (2 x CAr-H),
123.6 (2 x CAr-H), 125.8 (CAr-H), 125.9 (CAr-H), 128.3 (2 x CAr-H(a) + 2 x
CAr-H(b)), 128.4 (2 x CAr-H(a) + 2 x CAr-H(b)), 128.7 (2 x CAr-H), 128,8 (2
x CAr-H), 138.6 (CAr), 138.7 (CAr), 141.6 (CAr), 141.7 (CAr), 149.1 (CAr),
149.1 (CAr), 164.1 (C=O), 164.5 (C=O). HRMS (ESI+) calcd for
[NaC18H20N4O5]+ 395.1326; found 395.1329 [M + Na]+.
NMR (300 MHz, DMSO-d6) δ 0.96-1.04 (m, 3Ha + 3Hb, RCH3), 1.40-1.53
(m, 5Ha + 5Hb, Alk-H), 3.56-3.37 (m, 1Ha + 1Hb, NCHRR’), 4.72-4.88 (m,
1Ha + 1Hb, RCHR’NO2), 5.34 (dd, J1 = 5.4 Hz, J2 = 4.6 Hz, 1Hb, N-NH-C),
5.47 (t, J = 6.0 Hz, 1Ha, N-NH-C), 7.94-7.98 (m, 2Hb, Ar-H) 8.04-8.07 (m,
2Ha, Ar-H), 8.29-8.35 (m, 2Ha + 2 Hb, Ar-H), 10.13 (d, J = 5.6 Hz, 1Hb,
(RC=O)NHR), 10.36 (d, J = 6.3 Hz, 1Ha, (RC=O)NHR). 13C-NMR (75
MHz, DMSO-d6) δ 10.2 (CH3), 10.8 (CH3), 12.7 (CH3), 13.7 (CH3), 20.4
(CH2), 22.5 (CH2), 63.3 (NCHRR’), 63.7 (NCHRR’), 83.9 (RCHR’NO2),
84.0 (RCHR’NO2), 123.5 (2 x CAr-H), 123.6 (2 x CAr-H), 128.7 (2 x CAr-H),
128.7 (2 x CAr-H), 138.5 (CAr), 138.7 (CAr), 149.1 (CAr(a) + CAr(b)), 163.9
(C=O), 164.4 (C=O). HRMS (ESI+) calcd for [NaC12H16N4O5]+ 319.1013;
found 319.1020 [M + Na]+.
4-Nitro-N'-(2-nitrononan-3-yl)benzohydrazide (4kb)
From hydrazone 1k (27.73 mg, 0.1 mmol) and nitroethane (2b) (1 mL,
12.6 mmol), after seven days at -20 °C, compound 4kb was purified by
column chromatography in n-hexane/ethyl acetate 8:2 to afford 9.34 mg
of a mixture of diastereomers (2.2:1 d.r.) as a yellow oil (27% yield). The
corresponding ee (72%) was determined by HPLC using a Daicel
Chiralpak IC column (n-hexane/tetrahydrofuran 90:10, flow rate
1
mL·min-1, λ = 255.5 nm): τmajor = 24.7 min; τminor = 16.0 min. IR (cm-1)
3282 (N-H), 2950, 2917, 1651 (C=O), 1600, 1547 (N-H), 1525 (NO2),
1456, 1376, 1345 (NO2), 1300, 867, 849, 718. 1H-NMR (300 MHz,
DMSO-d6) δ 0.78-0.90 (m, 3Ha + 3Hb, RCH3), 0.97-1.60 (m, 13Ha + 13Hb,
Alk-H), 3.38-3.49 (m, 1H, NCHRR’), 3.54-3.65 (m, 1H, NCHRR’), 4.71-
4.87 (m, 1Ha + 1Hb, RCHR’NO2), 5.30-5.34 (m, 1Hb, N-NH-C), 5.45 (t, J =
5.9 Hz, 1Ha, N-NH-C), 7.93-7.97 (m, 2Hb, Ar-H), 8.03-8.07 (m, 2Ha, Ar-H),
General procedure for the calculation of initial rates.
A solution of mesitylene (0.25 M), as internal standard, in CDCl3 (200 µl)
is added to a mixture of hydrazone (1h, 0.05 or 0.025 mmol) and quinine
(3a, 0.015 or 0.03 mmol) in a vial. The resulting mixture is stirred to form
This article is protected by copyright. All rights reserved.